Melanoma News Today

    Skip to content
    • Home
    • About Melanoma
    • Keytruda (Pembrolizumab)
    • Melanoma Clinical Trials
    • Contact Us
    June 8, 2017August 24, 2022

    Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

    News
    Patients with unresectable or metastatic melanoma who were treated with Keytruda (pembrolizumab) in a pivotal clinical trial showed superior and sustained time to disease progression when compared to those treated with Yervoy (ipilimumab). ... Read more
    June 6, 2017

    New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

    News
    Castle Biosciences presented three abstracts on the validity of using its 31-Gene Expression Profile (GEP) Test for melanoma prognosis at the American Society of Clinical Oncology (ASCO) 2017 annual meeting June 2-6 ... Read more
    June 1, 2017June 2, 2017

    Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

    News
    Biothera Pharmaceuticals will present the detailed study design of the IMPRIME-1 clinical trial at the upcoming 2017 ASCO Annual Meeting June 2-6 in Chicago. The trial is currently enrolling advanced melanoma or triple ... Read more
    May 30, 2017

    Researchers Provide New Insights into Melanoma Immune Resistance

    News
    A new study presents detailed information into the processes used by cancer cells to evade and resist the immune response. Researchers studied how the interferon gamma pathway guides cell signaling in melanoma cells by mapping the molecules and ... Read more
    May 25, 2017May 25, 2017

    New Clinical Trial Underway for Treatment of Advanced Melanoma

    News
    A new clinical trial is underway assessing the addition of the first-in-class AXL kinase inhibitor, BGB324, to standard of care treatment for patients with advanced unresectable or metastatic melanoma. The Phase 1/2 clinical trial ... Read more
    May 23, 2017May 23, 2017

    Skin Cancer Awareness Month Brings Sun Safety to Schools

    News
    Educating people of all ages, particularly children, about the dangers of sun exposure is urgent to preventing the increased prevalence of melanoma and skin cancer, the Skin Cancer Foundation reported in a press release. The ... Read more
    May 18, 2017

    First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma

    News
    The first patient has been enrolled in Targovax‘s pilot clinical trial for advanced or unresectable melanoma patients whose cancer progressed after treatment with checkpoint inhibitors. The study is being conducted at Memorial ... Read more
    May 16, 2017

    ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial

    News
    The combination of ImmunoPulse IL-12 and the anti-PD-1 therapy Keytruda (pembrolizumab) soon will be tested in a Phase 2 trial for treatment of metastatic melanoma. The study, called PISCES, is part of ... Read more
    May 11, 2017

    Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial

    News
    Adding the small molecule MEK inhibitor binimetinib to the BRAF inhibitor encorafenib was safe and significantly prolonged the time to disease progression or death in patients with BRAF-mutant advanced, unresectable, or metastatic ... Read more
    May 9, 2017May 9, 2017

    Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize

    News
    The Pershing Square Sohn Cancer Research Alliance has announced the six winners of the fourth edition of the annual Pershing Square Sohn Prize for Young Investigators in Cancer Research, one ... Read more
    May 4, 2017

    Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma

    News
    Castle Biosciences’ DecisionDx-Melanoma test can be used to accurately predict cancer recurrence and metastasis in patients with head and neck melanoma, the company announced. Studies found that the accuracy of the ... Read more
    April 25, 2017

    IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group

    News
    Prima Biomed, an Australian biotechnology company developing immunotherapies for cancer and autoimmune diseases, announced it has received approval for the third cohort of its Phase 1 melanoma trial (NCT02676869), TACTI-mel. ... Read more
    April 18, 2017April 18, 2017

    Study Finds Entrectinib Safe, Effective for Patients with Melanoma and Other Cancers

    News
    Ignyta’s candidate product entrectinib has shown promise as a treatment for several cancer types including melanoma, according to results of two Phase 1 clinical trials. Treatment with entrectinib was well-tolerated ... Read more
    April 13, 2017

    Combining IMO-2125 and Yervoy Shows Promise in Certain Metastatic Melanoma Patients

    News
    Combining Idera Pharmaceuticals‘ intratumoral IMO-2125 treatment with Yervoy (ipilimumab) may be a promising treatment approach for patients with metastatic melanoma who are refractory to anti-PD-1 therapies, according to preliminary data from ... Read more
    April 11, 2017

    Bacteria-derived Therapy AdVCA0848 Improves Survival in Mice with Melanoma, Study Indicates

    News
    A new therapy that activates a protein pathway to stifle melanoma tumor growth has shown promise as a treatment for the disease, a study reports. A single injection of the ... Read more
    April 6, 2017

    Opdivo, Yervoy Combo Improved Survival in Advanced Melanoma Phase 3 Trial

    News
    Opdivo (nivolumab) in combination with Yervoy (ipilimumab), as well as Opdivo alone, outperformed Yervoy monotherapy in terms of overall survival in a Phase 3 clinical trial of previously untreated patients ... Read more
    April 4, 2017

    Early-stage Eye Melanoma Trial Tests Less-invasive Treatment Approach

    News
    Patients with ocular melanoma, a type of melanoma that develops in the eye, have a potentially new and groundbreaking treatment option being assessed in a Phase 1 clinical trial. The ... Read more
    March 30, 2017

    Nanoparticles Carrying Anticancer Medication May Be New Weapon Against Melanoma

    News
    Researchers at the Penn State College of Medicine developed a novel drug to fight melanoma called CelePlum-777, a set of nanoparticles loaded with the anticancer drugs celecoxib and plumbagin, and that ... Read more
    March 28, 2017March 28, 2017

    Expert Panel Recommends National Guidelines to Improve Melanoma Screening

    News
    A group of experts have outlined recommendations for multiple melanoma screening to initiate the implementation of a national consensus on screening procedures. Currently there is no national screening guideline for melanoma, ... Read more
    March 23, 2017March 23, 2017

    DecisionDx-Melanoma Test Shows Promise in Predicting Distant Metastasis

    News
    Castle Biosciences‘ DecisionDx-Melanoma gene expression profile (GEP) test is a promising tool to identify melanoma patients at high risk of developing metastatic disease, according to recently presented data from five studies ... Read more

    Posts navigation

    Older posts

    Never miss another melanoma update.

    * indicates required

    Recent Melanoma Articles

    • clinical trial results

      Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

      June 8, 2017

    • DecisionDx-Melanoma prognosis test

      New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

      June 6, 2017

    • Biothera presents trial results

      Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

      June 1, 2017

    • melanomas that resist immune response

      Researchers Provide New Insights into Melanoma Immune Resistance

      May 30, 2017

    • nevus mole prognosis BGB324

      New Clinical Trial Underway for Treatment of Advanced Melanoma

      May 25, 2017

    You May Also Like…..

    Opdivo, Yervoy Combo Improved Survival in Advanced Melanoma Phase 3 Trial

    April 6, 2017

    Opdivo, Yervoy combination

    Researchers Link Alcohol Consumption to Risk of Developing Invasive Melanoma

    December 13, 2016

    Alcohol consumption and melanoma

    Expert Panel Recommends National Guidelines to Improve Melanoma Screening

    March 28, 2017

    melanoma screening guidelines
    Visit Melanoma News Today's profile on Pinterest.
    Bionews, Inc.
    3 W Garden St
Suite 700
Pensacola, FL 32502
Email: [email protected]
Phone: +1-800-936-1363

    Recent Posts

    • clinical trial results

      Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

      June 8, 2017

    • DecisionDx-Melanoma prognosis test

      New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

      June 6, 2017

    • Biothera presents trial results

      Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

      June 1, 2017

    • melanomas that resist immune response

      Researchers Provide New Insights into Melanoma Immune Resistance

      May 30, 2017

    • About Melanoma News Today
    • Contact Us
    • Terms of Service
    • Privacy Policy

    Disclaimer:

    Melanoma News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
    Copyright © 2013-2025 All rights reserved.